These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

254 related items for PubMed ID: 32949895

  • 41. Lacosamide dosing in patients receiving continuous renal replacement therapy.
    Chaijamorn W, Phunpon S, Sathienluckana T, Charoensareerat T, Pattharachayakul S, Rungkitwattanakul D, Srisawat N.
    J Intensive Care; 2023 Nov 09; 11(1):50. PubMed ID: 37946296
    [Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43. Population pharmacokinetics and simulations of imipenem in critically ill patients undergoing continuous renal replacement therapy.
    Li S, Xie F.
    Int J Antimicrob Agents; 2019 Jan 09; 53(1):98-105. PubMed ID: 30626495
    [Abstract] [Full Text] [Related]

  • 44. Antibiotic Exposure Profiles in Trials Comparing Intensity of Continuous Renal Replacement Therapy.
    Jang SM, Pai MP, Shaw AR, Mueller BA.
    Crit Care Med; 2019 Nov 09; 47(11):e863-e871. PubMed ID: 31397714
    [Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. Role of renal function in risk assessment of target non-attainment after standard dosing of meropenem in critically ill patients: a prospective observational study.
    Ehmann L, Zoller M, Minichmayr IK, Scharf C, Maier B, Schmitt MV, Hartung N, Huisinga W, Vogeser M, Frey L, Zander J, Kloft C.
    Crit Care; 2017 Oct 21; 21(1):263. PubMed ID: 29058601
    [Abstract] [Full Text] [Related]

  • 47. Beta-lactam antibiotic concentrations in critically ill patients with standard and adjusted dosages: A prospective observational study.
    Areskog Lejbman I, Torisson G, Resman F, Sjövall F.
    Acta Anaesthesiol Scand; 2024 Apr 21; 68(4):530-537. PubMed ID: 38407447
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. Population Pharmacokinetic Study of the Suitability of Standard Dosing Regimens of Amikacin in Critically Ill Patients with Open-Abdomen and Negative-Pressure Wound Therapy.
    Carrié C, Delzor F, Roure S, Dubuisson V, Petit L, Molimard M, Breilh D, Biais M.
    Antimicrob Agents Chemother; 2020 Mar 24; 64(4):. PubMed ID: 31964795
    [Abstract] [Full Text] [Related]

  • 55. Antibiotic Dosing in Continuous Renal Replacement Therapy.
    Shaw AR, Mueller BA.
    Adv Chronic Kidney Dis; 2017 Jul 24; 24(4):219-227. PubMed ID: 28778361
    [Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. Pharmacokinetics and dosing estimation of meropenem in Japanese patients receiving continuous venovenous hemodialysis.
    Kawano S, Matsumoto K, Hara R, Kuroda Y, Ikawa K, Morikawa N, Horino T, Hori S, Kizu J.
    J Infect Chemother; 2015 Jun 24; 21(6):476-8. PubMed ID: 25869915
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.